OCUP Ocuphire Pharma, Inc.

Ocuphire Pharma is a clinical-stage ophthalmic biopharmaceutical company focused on developing and commercializing therapies for the treatment of several eye disorders.

$3.49  -0.08 (-2.24%)
As of 12/06/2021 16:00:00 EST     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  11/10/2005
Outstanding shares:  17,300,481
Average volume:  5,331,322
Market cap:   $61,762,717
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    67577R102
ISIN:        US67577R1023
Valuation   (See tab for details)
PE ratio:   -5.31
PB ratio:   2.94
PS ratio:   104.86
Return on equity:   -364.68%
Net income %:   -12,733.45%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy